Resource library search

In this month's Microbe Talk, Lilly chats with microbiologist Prof Wilhelmina Huston about what science knows so far about the relationship between the vaginal microbiome - the composition of microbes that live on and within the vagina - and sexual health, including her recent research investigating how the microbial composition of the vagina can impact susceptibility to painful conditions, like pelvic inflammatory disease (PID). We also cover current treatments and where the future of treatment of STIs and other sexual health disorders is headed.

The Journal of Medical Microbiology (JMM) is pleased to announce the return of its popular online seminar series.

Control of gonorrhoea is dependent on successful antibiotic treatment, and the bacterium that causes the infection, Neisseria gonorrhoeae, has become increasingly resistance to every antibiotic used to treat it over the last 60 years. Today, at the Society for General Microbiology’s Annual Conference in Liverpool, Professor Cathy Ison explains the challenges facing the treatment of the disease, which threatens to become resistant to all antibiotics.

Infection with high-risk human papillomavirus (HR HPV) types 16 and 18 is responsible for around 70-80% of cervical cancers. A study conducted by Public Health England and presented today at the Society for General Microbiology's Annual Conference shows a reduction in these two HR HPV types – which are included in the HPV vaccines used – in sexually active young women in England.